Home GeneSys

GeneSys

APLICATIONS

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Harish Chawla - June 22, 2023 0

VYVGART® Hytrulo is the first FDA-approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG) SAN DIEGO, June 20, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme")...

Interview Questions – Medical Representative

April 20, 2020

Most Important Questions for Interview Preparation

April 7, 2020

Mistakes Manager Makes During Job Interviews – Critical and Common Interview...

April 16, 2020

HOT NEWS

Interview Questions

Most Important Questions for Interview Preparation

Learning and Development

Performance Analysis of Medical Representative | Analyzing Reports & Data by...

New Drug Approval

New Drug Approval | FDA Approves Colchicine (Lodoco) as First Anti-Inflammatory...

Learning and Development